Browsing Institut de Recerca Biomèdica de Lleida (IRBLleida) by Subject "Basal cell carcinoma"
Now showing items 1-2 of 2
-
Characterisation of the inflammatory response triggered by topical ingenol mebutate 0.05% gel in basal cell carcinoma
(Wiley; Australasian College of Dermatologists, 2020-01-16)Background/Objective Ingenol mebutate gel is approved for actinic keratosis field therapy, but little has been published as a treatment of basal cell carcinoma (BCC). Our objective is to characterise the histopathological ... -
Cytokeratin profile of basal cell carcinomas according to the degree of sun exposure and to the anatomical localization
(Wolters Kluwer Health, Inc.; International Society of Dermatopathology (ISDP), 2018)Basal cell carcinoma (BCC) seems to originate from ultraviolet light-induced mutations involving the bulge or the outer sheath of the hair follicle cells. However, the etiopathogenic mechanisms involved in the development ...